Inhibition of lipid synthesis in Bacillus amyloliquefaciens by inhibitors of protein synthesis.
D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001407:Bacillus / Q000187:drug effects / Q000378:metabolism*; D001426:Bacterial Proteins / Q000096:biosynthesis; D002247:Carbon Isotopes; D002701:Chloramphenicol / Q000494:pharmacology*; D002855:Chromatography, Thin Layer; D007700:Kinetics; D008055:Lipids / Q000096:biosynthesis*; D010649:Phenylalanine / Q000378:metabolism; D010743:Phospholipids / Q000096:biosynthesis; D012329:RNA, Bacterial / Q000096:biosynthesis; D012293:Rifampin / Q000494:pharmacology*; D013752:Tetracycline / Q000494:pharmacology*; D014498:Uracil / Q000378:metabolism
D000903:Antibiotics, Antineoplastic; D001426:Bacterial Proteins; D002247:Carbon Isotopes; D008055:Lipids; D010743:Phospholipids; D012329:RNA, Bacterial; D010649:Phenylalanine; D014498:Uracil; D002701:Chloramphenicol; D013752:Tetracycline; D012293:Rifampin